According to preliminary research results, a corona vaccine from the pharmaceutical company Moderna is 94.5 percent effective in preventing infection with the coronavirus.
Moderna is working on the vaccine mRNA-1273. European countries have already ordered tens of millions of doses thereof.
Competitor Pfizer previously reported that its potential vaccine is 90 percent effective.